Harvard Bioscience, Inc. to Participate in The Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. to Participate in The Benchmark Healthcare House Call Virtual Conference
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET. The Company will also be hosting one-on-one meetings with investors in conjunction with the Conference.
馬薩諸塞州霍利斯頓，2024年5月16日（GLOBE NEWSWIRE）——哈佛生物科學公司（納斯達克股票代碼：HBIO）今天宣佈，董事長兼首席執行官吉姆·格林和首席財務官詹妮弗·科特將參加2024年5月22日的Benchmark Healthcare House電話會議虛擬會議，並定於美國東部時間上午9點至9點40分進行爐邊談話。該公司還將在會議期間與投資者舉行一對一的會議。
To register for the presentation, or to schedule a one-on-one meeting, please visit the Benchmark website at 2024 Benchmark Healthcare House Call Virtual Conference.
如需報名參加演示或安排一對一會議，請在 2024 年 Benchmark Healthcare House 電話會議虛擬會議上訪問 Benchmark 網站。